ADVERUM
Live / Registered — Registered — Section 71 accepted (as of 03 Jul 2024)
What this means for you
Registered since 10 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79194977
- Registration number
- 5303797
- Mark type
- Stylized text
- Filed
- 25 Jul 2016
- Published for opposition
- 25 Jul 2017
- Registered
- 10 Oct 2017
- Attorney of record
- Linda Joy Kattwinkel
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases
Owner
- Adverum Biotechnologies, Inc., CA, US
- Adverum Biotechnologies, Inc., Menlo Park CA 94025, CA, US
- Adverum Biotechnologies, Inc., Menlo Park CA 94025, CA, US
Prosecution history
- 03 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 03 Jul 2024 — REGISTERED-SEC.71 ACCEPTED
- 21 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Sept 2023 — TEAS SECTION 71 RECEIVED
- 04 Feb 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 20 Jan 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 10 Oct 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 16 Feb 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Jan 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Jan 2018 — FINAL DISPOSITION PROCESSED
- 10 Jan 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 10 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 14 Sept 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Aug 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Aug 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED